Home
Matti Narkia's Library tagged → View Popular
Vitamin D Shows Heart Benefits in Study - Well Blog - NYTimes.com
"A new study suggests many Americans aren’t getting anywhere nearly enough of the vitamin, and it may be affecting their heart health.
In the study, researchers looked at tens of thousands of healthy adults 50 and older whose vitamin D levels had been measured during routine checkups. A majority, they found, were deficient in the vitamin. About two-thirds had less vitamin D in their bloodstreams than the authors considered healthy, and many were extremely deficient.
Less than two years later, the researchers found, those who had extremely low levels of the vitamin were almost twice as likely to have died or suffered a stroke than those with adequate amounts. They also had more coronary artery disease and were twice as likely to have developed heart failure.
The findings, which are being presented today at an American Heart Association conference in Orlando, don’t prove that lack of vitamin D causes heart disease; they only suggest a link between the two. "
Low Vitamin D Levels May Raise Heart Risk
"Study Shows Vitamin D Supplements May Be Useful in Preventing Heart Disease
Nov. 16, 2009 (Orlando, Fla.) -- Some men with low levels of vitamin D in their blood are at particularly high risk of developing heart disease and weakened bones that can lead to osteoporosis, researchers report.
In a study of more than 1,000 men, those with low levels of both vitamin D and the sex hormone estrogen were at significantly increased risk of having cardiovascular disease, says study head Erin Michos, MD, a cardiologist at Johns Hopkins.
"They were also at dramatically increased risk of osteopenia," or bone loss that can lead to osteoporosis, she says.
"Our results suggest that vitamin D supplements, which are already prescribed to treat osteoporosis, may also be useful in preventing heart disease," Michos tells WebMD.
Men with low levels of vitamin D and testosterone, on the other hand, were not at heightened risk for heart disease or osteopenia."
Meeting 2: Committee to Review Dietary Reference Intakes for Vitamin D and Calcium - Institute of Medicine
The second committee meeting was held August 4-5, 2009 in Washington, DC and included an Information-Gathering Workshop on August 4, 2009. The agenda for this workshop is below, along with the PowerPoint presentations that were used by the speakers during the workshop.
Please note, online presentations from this meeting are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations. Additional copyright and legal policies of The National Academies can be read in the National Academies Legal Statement.
Dietary Reference Intakes for Vitamin D and Calcium - Institute of Medicine
Dietary Reference Intakes for Vitamin D and Calcium
An IOM committee has been named to undertake a study to assess current relevant data and update as appropriate the DRIs for vitamin D and calcium. The review will include consideration of chronic and non-chronic disease indicators. The study will also incorporate, as appropriate, systematic evidence-based reviews of the literature and an assessment of potential indicators of adequacy and of excess intake. Indicators for adequacy and excess will be selected based on the strength and quality of the evidence and the demonstrated public health significance, taking into consideration sources of uncertainty in the evidence.
Meetsee - Connect your distributed workforce
Meetsee combines powerful productivity and communication tools with an immersive virtual office experience that mirrors real life. With Meetsee anyone can chat, webcam, share files, and collaborate on documents with no download required. Meetsee also integrates seamlessly with common applications and services like Microsoft PowerPoint, SharePoint, RSS, Twitter, Flickr, Facebook, and YouTube.
Meetup: World's largest community of local Meetups, clubs and groups!
"A convenient, non-threatening way to connect to other people who share similar interests and live nearby." \n- Time
BioVex To Report Phase I/II Clinical Trial Results For The Front Line Treatment Of Head And Neck Cancer
BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced that the results from a Phase I/II combination study in previously untreated patients with head and neck cancer will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 29, 2009 - June 2, 2009 in Orlando, FL.
Phase I trial of Seneca Valley Virus (NTX-010), a newly discovered systemically deliverable oncolytic picornavirus, in patients with solid tumors with neuroendocrine features - Journal of Clinical Oncology, 2007 ASCO Annual Meeting
Phase I trial of Seneca Valley Virus (NTX-010), a newly discovered systemically deliverable oncolytic picornavirus, in patients with solid tumors with neuroendocrine features.
C. M. Rudin, D. Lansey, K. D. Burroughs, L. M. Hales, J. R. Neefe, P. S. Reddy and P. L. Hallenbeck
Johns Hopkins Univ, Baltimore, MD; Neotropix, Inc., Malvern, PA.
Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol 25, No 18S (June 20 Supplement), 2007: 18014
© 2007 American Society of Clinical Oncology.
Conclusions: NTX-010 is a novel first-in-class anticancer virus with selective tropism for tumors with neuroendocrine features. This is the first anticancer virus given intravenously with documented selective intratumoral infection and replication. Administration was well tolerated. Safety data and viral kinetics will be presented.
Newswise Medical News | Study on Role of Antioxidants in Reducing Chemotherapy Toxicity to Be Presented at ASCO
A new study showing a reduction in the toxic side effects of ROS-generating chemotherapies with concurrent antioxidant supplementation will be presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) that takes place June 1-5 at McCormick Place in Chicago. According to the study’s authors, mitigating chemotherapy toxicity by supplementing with antioxidants may improve survival rates and tumor response by helping patients complete their prescribed treatment cycles.
Head and Neck Cancer Summary from 2006 ASCO Annual Meeting
American Society of Clinical Oncology Meeting 2006.
O'Reilly Open Source Convention 2007 • July 23-27, 2007 • Portland, Oregon
Presentation files will be made available after the session has concluded and the speaker has given us the files. Check back if you don't see the file you're looking for—it might be available later! (However, please note some speakers choose not to shar
ACR Meeting Reports - American Association for Cancer Research
AACR journals routinely publish peer-reviewed Meeting Reports written by high-profile scientists. In addition, the journals occasionally publish Supplement issues containing the proceedings of important meetings in full-length peer-reviewed articles.
American Association for Cancer Research (AACR)
AACR is the oldest and largest scientific organization in the world focused on every aspect of high-quality, innovative cancer research. Its reputation for scientific breadth and excellence attract the premier researchers in the field. The programs and se
Head and Neck Cancer Oral Presentations from 2006 ASCO Annual Meeting
American Society of Clinical Oncology 2006 Meeting.
Selected Tags
Related Tags
Sponsored Links
Top Contributors
Groups interested in meeting
-
PLN: Formal & Informal
I will list conferences, cl...
Items: 154 | Visits: 78
Created by: Sheryl A. McCoy
-
Widgets for the Masses-- Cool Tools, 2008 AALL Annual Meeting
This list features the link...
Items: 28 | Visits: 72
Created by: Debbie Ginsberg
-
Chronic
Items: 27 | Visits: 66
Created by: kotzeh
Highlighter, Sticky notes, Tagging, Groups and Network: integrated suite dramatically boosting research productivity. Learn more »
Join Diigo